Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively

被引:89
作者
Paavonen, K
HorelliKuitunen, N
Chilov, D
Kukk, E
Pennanen, S
Kallioniemi, OP
Pajusola, K
Olofsson, B
Eriksson, U
Joukov, V
Palotie, A
Alitalo, K
机构
[1] HAARTMAN INST,MOLEC CANC BIOL LAB,SF-00014 HELSINKI,FINLAND
[2] HELSINKI UNIV,CENT HOSP,DEPT CLIN CHEM,HELSINKI,FINLAND
[3] TAMPERE UNIV,CANC GENET LAB,INST MED TECHNOL,SF-33101 TAMPERE,FINLAND
[4] LUDWIG INST CANC RES,S-10401 STOCKHOLM,SWEDEN
关键词
growth substances; gene; cardiovascular diseases;
D O I
10.1161/01.CIR.93.6.1079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Vascular endothelial growth factor (VEGF) is an important regulator of endothelial cell proliferation, migration, and permeability during embryonic vasculogenesis as well as in physiological and pathological angiogenesis. The recently isolated VEGF-B and VEGF-C cDNAs encode novel growth factor genes of the VEGF family. Methods and Results Southern blotting and polymerase chain reaction analysis of somatic cell hybrids and fluorescence in situ hybridization (FISH) of metaphase chromosomes were used to assess the chromosomal localization of VEGF-B and VEGF-C genes. The VEGF-B gene was found on chromosome 11q13, proximal to the cyclin D1 gene, which is amplified in a number of human carcinomas. However, VEGF-B was not amplified in several mammary carcinoma cell lines containing amplified cyclin D1. The VEGF-C gene was located on chromosome 4q34, close to the human aspartylglucosaminidase gene previously mapped to 4q34-35. Conclusions The VEGF-B locus in 11q13 and the VEGF-C locus in 4q34 are candidate targets for mutations that lead to vascular malformations or cardiovascular diseases.
引用
收藏
页码:1079 / 1082
页数:4
相关论文
共 29 条
[1]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[2]   PURIFICATION AND CHARACTERIZATION OF A NATURALLY-OCCURRING VASCULAR ENDOTHELIAL GROWTH-FACTOR PLACENTA GROWTH-FACTOR HETERODIMER [J].
DISALVO, J ;
BAYNE, ML ;
CONN, G ;
KWOK, PW ;
TRIVEDI, PG ;
SODERMAN, DD ;
PALISI, TM ;
SULLIVAN, KA ;
THOMAS, KA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7717-7723
[3]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[4]   MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS [J].
FERRARA, N ;
HOUCK, K ;
JAKEMAN, L ;
LEUNG, DW .
ENDOCRINE REVIEWS, 1992, 13 (01) :18-32
[5]   ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM [J].
FONG, GH ;
ROSSANT, J ;
GERTSENSTEIN, M ;
BREITMAN, ML .
NATURE, 1995, 376 (6535) :66-70
[6]   A HEPARIN-BINDING FORM OF PLACENTA GROWTH-FACTOR (PLGF-2) IS EXPRESSED IN HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS AND IN PLACENTA [J].
HAUSER, S ;
WEICH, HA .
GROWTH FACTORS, 1993, 9 (04) :259-268
[7]  
HEISKANEN M, IN PRESS GENET ANAL
[8]  
Joukov V, 1996, EMBO J, V15, P290
[9]   EXPRESSION OF THE FMS-LIKE TYROSINE KINASE-4 GENE BECOMES RESTRICTED TO LYMPHATIC ENDOTHELIUM DURING DEVELOPMENT [J].
KAIPAINEN, A ;
KORHONEN, J ;
MUSTONEN, T ;
VANHINSBERGH, VWM ;
FANG, GH ;
DUMONT, D ;
BREITMAN, M ;
ALITALO, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3566-3570
[10]  
KAIPAINEN A, 1994, CANCER RES, V54, P6571